Mirna Therapeutics Appoints CSO
This article was originally published in Scrip
Mirna Therapeutics has appointed Miguel Barbosa executive vice-president and chief scientific officer. Barbosa previously served in leadership roles at various Johnson & Johnson (J&J) subsidiaries and most recently he was executive in residence, therapeutic innovation at J&J Innovation. Prior to this he was vice-president of immunology research and external innovation at another J&J company, Janssen Research and Development LLC.
Register for our free email digests: